Literature DB >> 4606887

Parkinson's disease and levodopa. A five-year follow-up and review.

C H Markham, L J Treciokas, S G Diamond.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4606887      PMCID： PMC1129565     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  75 in total

1.  REGIONAL DISTRIBUTION OF CIRCULATING BLOOD DURING SUBMERSION ASPHYXIA IN THE DUCK.

Authors:  K JOHANSEN
Journal:  Acta Physiol Scand       Date:  1964 Sep-Oct

2.  PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

Authors:  J C STEELE; J C RICHARDSON; J OLSZEWSKI
Journal:  Arch Neurol       Date:  1964-04

3.  [Nigro-striate and cerebello-nigro-striate degeneration. (Clinical uniqueness and pathological variability of presenile degeneration of the extrapyramidal rigidity type].

Authors:  R ADAMS; L VAN BOGAERT; H VAN DER EECKEN
Journal:  Psychiatr Neurol (Basel)       Date:  1961

4.  Neostriatal choline acetylase and cholinesterase following selective brain lesions.

Authors:  P L McGeer; E G McGeer; H C Fibiger; V Wickson
Journal:  Brain Res       Date:  1971-12-10       Impact factor: 3.252

5.  [The capillary enzyme barrier for DOPA at the level of some brain stem nuclei in the rat].

Authors:  J Constantinidis; G Bartholini; F Geissbühler; R Tissot
Journal:  Experientia       Date:  1970-04-15

6.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

7.  Levodopa's awakening effect on patients with Parkinsonism.

Authors:  G G Marsh; C M Markham; R Ansel
Journal:  J Neurol Neurosurg Psychiatry       Date:  1971-06       Impact factor: 10.154

8.  Status of the clinical evaluation of levodopa in the treatment of Parkinson's disease and syndrome.

Authors:  H M Langrall; C Joseph
Journal:  Clin Pharmacol Ther       Date:  1971 Mar-Apr       Impact factor: 6.875

Review 9.  Dopamine (3-hydroxytyramine) and brain function.

Authors:  O Hornykiewicz
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

10.  L-Dopa (L-3,4-dihydroxyphenylanine)--its clinical effects in parkinsonism.

Authors:  M D Yahr; R C Duvoisin; M M Hoehn; M J Schear; R E Barrett
Journal:  Trans Am Neurol Assoc       Date:  1968
View more
  10 in total

Review 1.  Neurochemistry and behavior in man.

Authors:  G S Omenn
Journal:  West J Med       Date:  1976-12

2.  Current therapy of Parkinson's disease.

Authors:  J C Ramseyer
Journal:  West J Med       Date:  1975-08

3.  Editorial: Long-term assessment of levodopa therapy in Parkinson's disease.

Authors:  A Barbeau
Journal:  Can Med Assoc J       Date:  1975-06-21       Impact factor: 8.262

4.  Cerebral atrophy and long-term response to levodopa in Parkinson's disease.

Authors:  E Schneider; P A Fischer; P Jacobi; H Becker; M Beyer
Journal:  J Neurol       Date:  1979       Impact factor: 4.849

5.  Mortality of patients with Parkinson's disease treated with levodopa.

Authors:  R J Marttila; U K Rinne; T Siirtola; V Sonninen
Journal:  J Neurol       Date:  1977-10-07       Impact factor: 4.849

6.  Suppression of "rubral" tremor with levodopa.

Authors:  L J Findley; M A Gresty
Journal:  Br Med J       Date:  1980-10-18

Review 7.  When should levodopa therapy be initiated in patients with Parkinson's disease?

Authors:  Irene A C Halkias; Ihtsham Haq; Zhigao Huang; Hubert H Fernandez
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

8.  Present morality in parkinson's disease: the ratio of observed to expected deaths with a method to calculate expected deaths.

Authors:  S G Diamond; C H Markham
Journal:  J Neural Transm       Date:  1976       Impact factor: 3.575

9.  Electrical properties of motor units in Parkinsonism and a possible relationship with bradykinesia.

Authors:  H S Milner-Brown; M A Fisher; W J Weiner
Journal:  J Neurol Neurosurg Psychiatry       Date:  1979-01       Impact factor: 10.154

10.  Blockers of monoamine transporters influence high dopamine concentration uptake in rat brain slices.

Authors:  M Yu Iniouchine; D A Sibarov; A B Volnova; C A Jimenez-Rivera; A D Nozdrachev
Journal:  Dokl Biol Sci       Date:  2008 Mar-Apr
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.